- Functional Differences of the Gut Microbiome in Primary Sclerosing Cholangitis and Primary Biliary Cholangitis Inform Pathogenesis and Therapeutic Intervention
Marios Nikolaidis, PhD, Presenter
Cholestatic and Autoimmune
7:53 AM - 7:58 AM
Nov
09
2025
Washington, D.C.
Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray
Kazumichi Abe, MD, PhD, Presenter
Cholestatic and Autoimmune
7:58 AM - 8:03 AM
Nov
09
2025
Washington, D.C.
Single-Cell Spatial Transcriptomics Reveals TNFSF Signaling Dynamics and Potential Treatment Targets in Pediatric Onset Autoimmune Liver Diseases